DataSheet1_Immobilized Fe3O4-Polydopamine-Thermomyces lanuginosus Lipase-Catalyzed Acylation of Flavonoid Glycosides and Their Analogs: An Improved Insight Into Enzymic Substrate Recognition.PDF

The conversion of flavonoid glycosides and their analogs to their lipophilic ester derivatives was developed by nanobiocatalysts from immobilizing Thermomyces lanuginosus lipase (TLL) on polydopamine-functionalized magnetic Fe3O4 nanoparticles (Fe3O4-PDA-TLL). The behavior investigation revealed that Fe3O4-PDA-TLL exhibits a preference for long chain length fatty acids (i.e., C10 to C14) with higher reaction rates of 12.6–13.9 mM/h. Regarding the substrate specificity, Fe3O4-PDA-TLL showed good substrate spectrum and favorably functionalized the primary OH groups, suggesting that the steric hindrances impeded the secondary or phenolic hydroxyl groups of substrates into the bonding site of the active region of TLL to afford the product.</p

Additional file 1: of Long non-coding RNA HOTAIR polymorphism and susceptibility to cancer: an updated meta-analysis

Table S1. Genotype frequency distributions of HOTAIR polymorphisms and cancer risk. (DOCX 38 kb

Additional file 2: of Long non-coding RNA HOTAIR polymorphism and susceptibility to cancer: an updated meta-analysis

Figure S1. Sensitivity analyses for HOTAIR polymorphisms and cancer risk in heterozygous model. (A) rs920778, (B) rs4759314, (C) rs7958904, (D) rs1899663, (E) rs874945, and (F) rs12826786. (JPEG 754 kb

MOESM1 of Clinicopathological and prognostic significance of long noncoding RNA MALAT1 in human cancers: a review and meta-analysis

Additional file 1: Table S1. The characteristics of the included studies in the meta-analysis

MOESM3 of Clinicopathological and prognostic significance of long noncoding RNA MALAT1 in human cancers: a review and meta-analysis

Additional file 3: Table S3. Association between MALAT1 expression and clinicopathological features of cancers

MOESM2 of Clinicopathological and prognostic significance of long noncoding RNA MALAT1 in human cancers: a review and meta-analysis

Additional file 2: Table S2. Characteristics of studies for survival outcomes included in the meta-analysis